Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NS4A-2K-NS4B precursor is a cleavage intermediate in Dengue virus nonstructural polyprotein processing, linking the integral membrane proteins NS4A and NS4B via a 23-residue 2K fragment that serves as a signal sequence for NS4B translocation to the ER lumen.[1][4] This precursor specifically interacts with Dengue virus NS1 protein through residues in NS1's Wing connector domain (e.g., G161 and W168), a binding essential for RNA replication and biogenesis of ER-derived viral replication organelles, but not required for vesicle packet formation independent of replication.[4][5] NS4A within the complex oligomerizes on curved ER membranes, anchors replication sites via host vimentin interactions, and induces membrane reshaping into vesicles and double-membrane structures, while NS4B contributes to replication complex recruitment and host immune antagonism.[1][2][3] The interaction between NS4A (residues 40-76, including transmembrane helix) and NS4B (residues 84-146) stabilizes the complex with high affinity (Kd ~50 nM), and mutations disrupting these contacts impair viral replication.[2] As part of Dengue virus replication machinery, targeting NS4A-2K-NS4B or its NS1 interaction offers potential antiviral strategies, though no clinical drugs are reported.[2][3][4] Conservation across DENV serotypes supports broad-spectrum inhibitor potential, but low homology to other flaviviruses complicates pan-flaviviral development.[3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NS4A-2K-NS4B precursor, Dengue virus (NS4A-2K-NS4B).